Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
Online ISSN : 1882-1499
Print ISSN : 1346-342X
ISSN-L : 1346-342X
Regular Articles
Antibacterial Treatment of Palmoplantar Pustulosis Shortens Hortens the Response Time and the Lymphocyte / Monocyte Ratio can Serve as a Biomarker of Palmoplantar Pustulosis
Kuninori IwayamaTakayuki ManabeMari KishibeMasaru HonmaYoshikazu Tasaki
Author information
JOURNAL FREE ACCESS

2020 Volume 46 Issue 10 Pages 567-575

Details
Abstract

Palmoplantar pustulosis (PPP) is a chronic inflammatory dermatosis characterized by sterile pustules on the palms and soles. To treat the symptoms, antimicrobial agents such as tetracyclines, macrolides, and cephalosporins are effective for PPP due to their anti-inflammatory effects. To date, there have been no reports on the response rates and time to response of the antibiotics and biomarkers to indicate the severity of PPP. In this study, we retrospectively investigated responsiveness against PPP and possible biomarkers from laboratory test data. During the 5-year study period, 65 PPP patients who visited Asahikawa Medical University Hospital were classified into two groups: non-responders (n = 22) and responders (n = 43). We compared patient background, PPP drugs and laboratory test values between the two groups. Among PPP drugs, the proportion of patients who received antimicrobial agents in the responder group was significantly higher than that in the non-responder group. Among the responder group with antimicrobial agents, the time to response was significantly shorter than that of the responder group without antimicrobial agents. In laboratory values, the changes in the levels of lymphocyte to monocyte ratio (LMR), total protein (TP), and albumin (ALB) in the responder group were significantly decreased compared with those in the non-responder group. These results suggest that antimicrobial agents contribute to the early symptomatic improvement of PPP and shortened the time to response. The reductions in LMR were observed with PPP improvement during the antimicrobial therapy, therefore, this laboratory item has the potential to serve as a biomarker for PPP.

Content from these authors
© 2020 Japanese Society of Pharmaceutical Health Care and Sciences
Previous article Next article
feedback
Top